留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

脱氢表雄酮在绝经后妇女中的作用

魏代敏 郁琦

魏代敏, 郁琦. 脱氢表雄酮在绝经后妇女中的作用[J]. 协和医学杂志, 2013, 4(1): 58-62. doi: 10.3969/j.issn.1674-9081.2013.01.013
引用本文: 魏代敏, 郁琦. 脱氢表雄酮在绝经后妇女中的作用[J]. 协和医学杂志, 2013, 4(1): 58-62. doi: 10.3969/j.issn.1674-9081.2013.01.013

脱氢表雄酮在绝经后妇女中的作用

doi: 10.3969/j.issn.1674-9081.2013.01.013
详细信息
    通讯作者:

    郁琦 电话:010-69156223, E-mail:yuqimd@163.com

  • 中图分类号: R592

  • [1] Longcope C. Adrenal and gonadal androgen secretion in normal females[J]. Clin Endocrinol Metab, 1986, 15:213-228. doi:  10.1016/S0300-595X(86)80021-4
    [2] Burger HG. Androgen production in women[J]. Fertil Steril, 2002, 77 Suppl 4:S3-S5. http://europepmc.org/abstract/med/12007895
    [3] Labrie F, Martel C, Balser J. Wide distribution of the serum dehydroepiandrosterone and sex steroid levels in postmenopausal women:role of the ovary?[J]. Menopause, 2011, 18:30-43. doi:  10.1097/gme.0b013e3181e195a6
    [4] Labrie F, Belanger A, Cusan L, et al. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging[J]. J Clin Endocrinol Metab, 1997, 82:2396-2402. doi:  10.1210/jcem.82.8.4160
    [5] Labrie F, Luu-The V, Labrie C, et al. DHEA and its transformation into androgens and estrogens in peripheral target tissues:intracrinology[J]. Front Neuroendocrinol, 2001, 22:185-212. doi:  10.1006/frne.2001.0216
    [6] Labrie F, Cusan L, Gomez JL, et al. Comparable amounts of sex steroids are made outside the gonads in men and women:strong lesson for hormone therapy of prostate and breast cancer[J]. J Steroid Biochem Mol Biol, 2009, 113:52-56. doi:  10.1016/j.jsbmb.2008.11.004
    [7] Labrie F, Dupont A, Belanger A, et al. Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer:a marked improvement in response and survival[J]. J Steroid Biochem, 1985, 23:833-841. doi:  10.1016/S0022-4731(85)80024-8
    [8] Fogle RH, Stanczyk FZ, Zhang X, et al. Ovarian androgen production in postmenopausal women[J]. J Clin Endocrinol Metab, 2007, 92:3040-3043. doi:  10.1210/jc.2007-0581
    [9] Couzinet B, Meduri G, Lecce MG, et al. The postmeno-pausal ovary is not a major androgen-producing gland[J]. J Clin Endocrinol Metab, 2001, 86:5060-5066. doi:  10.1210/jcem.86.10.7900
    [10] Williams MR, Dawood T, Ling S, et al. Dehydroepiandro-sterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors[J]. J Clin Endocrinol Metab, 2004, 89:4708-4715. doi:  10.1210/jc.2003-031560
    [11] Liu D, Dillon JS. Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells:evidence for a cell surface receptor[J]. Steroids, 2004, 69:279-289. doi:  10.1016/j.steroids.2004.02.004
    [12] Le Mee S, Hennebert O, Ferrec C, et al. 7beta-Hydroxy-epiandrosterone-mediated regulation of the prostaglandin synthesis pathway in human peripheral blood monocytes[J]. Steroids, 2008, 73:1148-1159. doi:  10.1016/j.steroids.2008.05.001
    [13] Enomoto M, Adachi H, Fukami A, et al. Serum dehydro-epiandrosterone sulfate levels predict longevity in men:27-year follow-up study in a community-based cohort (Tanushimaru study)[J]. J Am Geriatr Soc, 2008, 56:994-998. doi:  10.1111/j.1532-5415.2008.01692.x
    [14] Cappola AR, O'Meara ES, Guo W, et al. Trajectories of dehydroepiandrosterone sulfate predict mortality in older adults:the cardiovascular health study[J]. J Gerontol A Biol Sci Med Sci, 2009, 64:1268-1274. http://www.ncbi.nlm.nih.gov/pubmed/19713299
    [15] Ebeling P, Koivisto VA. Physiological importance of dehydroepiandrosterone[J]. Lancet, 1994, 343:1479-1481. doi:  10.1016/S0140-6736(94)92587-9
    [16] Casson PR, Toth MJ, Johnson JV, et al. Correlation of serum androgens with anthropometric and metabolic indices in healthy, nonobese postmenopausal women[J]. J Clin Endocrinol Metab, 2010, 95:4276-4282. doi:  10.1210/jc.2009-2390
    [17] Williams MR, Ling S, Dawood T, et al. Dehydroepiandro-sterone inhibits human vascular smooth muscle cell proliferation independent of ARs and ERs[J]. J Clin Endocrinol Metab, 2002, 87:176-181. doi:  10.1210/jcem.87.1.8161
    [18] Shufelt C, Bretsky P, Almeida CM, et al. DHEA-S levels and cardiovascular disease mortality in postmenopausal wo-men:results from the National Institutes of Health-National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE)[J]. J Clin Endocrinol Metab, 2010, 95:4985-4992. doi:  10.1210/jc.2010-0143
    [19] Akishita M, Hashimoto M, Ohike Y, et al. Association of plasma dehydroepiandrosterone-sulfate levels with endothelial function in postmenopausal women with coronary risk factors[J]. Hypertens Res, 2008, 31:69-74. doi:  10.1291/hypres.31.69
    [20] Yoshida S, Aihara K, Azuma H, et al. Dehydroepiandro-sterone sulfate is inversely associated with sex-dependent diverse carotid atherosclerosis regardless of endothelial function[J]. Atherosclerosis, 2010, 212:310-315. doi:  10.1016/j.atherosclerosis.2010.05.011
    [21] Christiansen JJ, Andersen NH, Sorensen KE, et al. Dehydroepiandrosterone substitution in female adrenal failure:no impact on endothelial function and cardiovascular para-meters despite normalization of androgen status[J]. Clin Endocrinol (Oxf), 2007, 66:426-433. doi:  10.1111/j.1365-2265.2007.02750.x
    [22] Baulieu EE, Robel P, Schumacher M. Neurosteroids:beginning of the story[J]. Int Rev Neurobiol, 2001, 46:1-32. doi:  10.1016/S0074-7742(01)46057-0
    [23] Schmidt PJ, Daly RC, Bloch M, et al. Dehydroepiandro-sterone monotherapy in midlife-onset major and minor depression[J]. Arch Gen Psychiatry, 2005, 62:154-162. doi:  10.1001/archpsyc.62.2.154
    [24] Takayanagi R, Goto K, Suzuki S, et al. Dehydroepiandro-sterone (DHEA) as a possible source for estrogen formation in bone cells:correlation between bone mineral density and serum DHEA-sulfate concentration in postmenopausal women, and the presence of aromatase to be enhanced by 1, 25-dihydroxyvitamin D3 in human osteoblasts[J]. Mech Ageing Dev, 2002, 123:1107-1114. doi:  10.1016/S0047-6374(01)00394-3
    [25] Tok EC, Ertunc D, Oz U, et al. The effect of circulating androgens on bone mineral density in postmenopausal women[J]. Maturitas, 2004, 48:235-242. doi:  10.1016/j.maturitas.2003.11.007
    [26] Callies F, Fassnacht M, van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency:effects on body composition, serum leptin, bone turnover, and exercise capacity[J]. J Clin Endocrinol Metab, 2001, 86:1968-1972. doi:  10.1210/jcem.86.5.7483
    [27] Voznesensky M, Walsh S, Dauser D, et al. The association between dehydroepiandosterone and frailty in older men and women[J]. Age Ageing, 2009, 38:401-406. doi:  10.1093/ageing/afp015
    [28] Baker WL, Karan S, Kenny AM. Effect of dehydroepiandrosterone on muscle strength and physical function in older adults:a systematic review[J]. J Am Geriatr Soc, 2011, 59:997-1002. doi:  10.1111/j.1532-5415.2011.03410.x
    [29] Arlt W, Callies F, van Vlijmen JC, et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency[J]. N Engl J Med, 1999, 341:1013-1020. doi:  10.1056/NEJM199909303411401
    [30] Alkatib AA, Cosma M, Elamin MB, et al. A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency[J]. J Clin Endocrinol Metab, 2009, 94:3676-3681. doi:  10.1210/jc.2009-0672
    [31] Baulieu EE, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging:contribution of the DHEAge Study to a sociobiomedical issue[J]. Proc Natl Acad Sci USA, 2000, 97:4279-4284. doi:  10.1073/pnas.97.8.4279
    [32] Jankowski CM, Gozansky WS, Kittelson JM, et al. Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens[J]. J Clin Endocrinol Metab, 2008, 93:4767-4773. doi:  10.1210/jc.2007-2614
    [33] Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy[J]. N Engl J Med, 2000, 343:682-688. doi:  10.1056/NEJM200009073431002
    [34] Srinivasan M, Irving BA, Frye RL, et al. Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men[J]. J Clin Endocrinol Metab, 2010, 95:1617-1625. doi:  10.1210/jc.2009-2000
    [35] Kritz-Silverstein D, von Muhlen D, Laughlin GA, et al. Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life:the DHEA and Well-Ness (DAWN) Trial[J]. J Am Geriatr Soc, 2008, 56:1292-1298. doi:  10.1111/j.1532-5415.2008.01768.x
    [36] Yamada S, Akishita M, Fukai S, et al. Effects of dehydro-epiandrosterone supplementation on cognitive function and activities of daily living in older women with mild to moderate cognitive impairment[J]. Geriatr Gerontol Int, 2010, 10:280-287. doi:  10.1111/j.1447-0594.2010.00625.x
    [37] Labrie F, Archer D, Bouchard C, et al. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy[J]. Menopause, 2009, 16:907-922. doi:  10.1097/gme.0b013e31819e8e2d
    [38] Panjari M, Bell RJ, Jane F, et al. The safety of 52 weeks of oral DHEA therapy for postmenopausal women[J]. Maturitas, 2009, 63:240-245. doi:  10.1016/j.maturitas.2009.03.020
    [39] Traish AM, Kang HP, Saad F, et al. Dehydroepiandro-sterone (DHEA)-a precursor steroid or an active hormone in human physiology (CME)[J]. J Sex Med, 2011, 8:2960-2982. doi:  10.1111/j.1743-6109.2011.02523.x
  • 加载中
计量
  • 文章访问数:  143
  • HTML全文浏览量:  54
  • PDF下载量:  9
  • 被引次数: 0
出版历程
  • 收稿日期:  2011-12-06
  • 刊出日期:  2013-01-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!